Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Treatment of Pneumocystis in COPD (the TOPIC Study) [Phase 1, Phase 2]
A Phase 1/2 trial investigating treatment of Pneumocystis in COPD was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 clinical trial comparing flow rate effects of the Respimat inhaler versus a metered-dose inhaler using Berodual in COPD and asthma p…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greece
Quality-of-life outcomes were assessed in COPD patients switched to a tiotropium/olodaterol fixed-dose combination; the trial in Greece is c…
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 adaptive trial evaluating inhaled treprostinil for pulmonary hypertension due to COPD was terminated; results were posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: N-acetylcysteine (NAC) for the Treatment of Acute Exacerbation of COPD [Phase 3]
Phase 3 clinical trial update for N-acetylcysteine in acute exacerbation of chronic obstructive pulmonary disease is noted, with the phase a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Effect of Staphylococcus and Neisseria Tablets on Clinical Outcome Among Patients With Chronic Obstructive Pulmonary Disease [Phase 4]
Phase 4 clinical trial investigating the effect of Staphylococcus and Neisseria tablets on outcomes in chronic obstructive pulmonary disease…
-
FDA approval · 2023-11-16FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental NDA for Fluticasone propionate and salmeterol, expanding its labeling and approved uses.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of ensifentrine in Chronic Obstructive Pulmonary Disease has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: A Study Using US Medical and Pharmacy Claim Records to Compare the Resource Use, Cost, and Outcomes of People With COPD Who Take Either Tiotropium + Olodaterol or Fluticasone + Umeclidinium + Vilanterol
A completed clinical trial comparing resource use, cost, and outcomes in COPD patients taking tiotropium + olodaterol versus fluticasone + u…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Tiotropium/Salmeterol Inhalation Powder in COPD [Phase 3]
Phase 3 trial update for tiotropium/salmeterol inhalation powder in chronic obstructive pulmonary disease has been terminated.
-
FDA approval · 2023-10-24FDA Approved: THEOPHYLLINE — Original Application (Harman Finochem Limited)
FDA approved Harman Finochem Limited's original application for Theophylline, enabling its generic manufacture and marketing under an ANDA O…
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)
A completed US-based observational study comparing Stiolto and Trelegy in COPD using pharmacy and medical claims; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Comparison of Corticosteroids vs Placebo on Duration of Ventilatory Support During Severe Acute Exacerbations of COPD Patients in the ICU [Phase 3]
A Phase 3 trial comparing corticosteroids to placebo on duration of ventilatory support in severe acute exacerbations of COPD in the ICU.
-
CLINICAL_TRIALS research · 2023-10-13Clinical Trial Update: A Study on Whether Patients Prefer the Spiriva® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 trial comparing patient preference between Spiriva Respimat and Spiriva Handihaler for COPD has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 1]
Phase 1 study assessing respiratory safety of lemborexant in adults with obstructive sleep apnea and in adults with chronic obstructive pulm…
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 study evaluating the mode of action of QBW251 in chronic obstructive pulmonary disease has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]
A Phase 3 clinical trial comparing fixed-dose combination inhaler of ipratropium/levosalbutamol versus free-dose combination in stable COPD …
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Clopidogrel for the Prevention of Exacerbations in Severe COPD [Phase 3]
Phase 3 trial update evaluating clopidogrel for preventing exacerbations in severe COPD, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Comprehensive Self-management Support for COPD Patients [NA]
A completed clinical trial evaluating comprehensive self-management support for COPD patients; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients [Phase 4]
Phase 4 trial update assessing a new plant-based high-energy oral nutritional supplement for malnourished patients, with multiple listed con…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: COPD Treatment by Transplantation of Autologous Bronchial Basal Cells [Phase 1, Phase 2]
Phase 1/2 trial update evaluating autologous bronchial basal cell transplantation as a treatment for COPD has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]
Phase 3 trial comparing fixed-dose combination versus free-dose combination of ipratropium and levosalbutamol in stable COPD patients; curre…
-
FDA approval · 2023-08-28FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for ProAir Digihaler (albuterol sulfate) from Teva Respiratory, LLC. The approval covers changes rel…
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial update for tiotropium/salmeterol inhalation powder in COPD has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Effects of Remote Patient Monitoring on Chronic Disease Management [NA]
Completed clinical trial examining the impact of remote patient monitoring on management of chronic diseases with results posted in 2023.